Medigen Biosciences Frequently Asked Questions (FAQ)
Where is Medigen Biosciences's headquarters?
Medigen Biosciences's headquarters is located at Madison.
What is Medigen Biosciences's latest funding round?
Medigen Biosciences's latest funding round is Incubator/Accelerator.
Who are the investors of Medigen Biosciences?
Investors of Medigen Biosciences include MGE Innovation Center.
Who are Medigen Biosciences's competitors?
Competitors of Medigen Biosciences include Prosarix, Kalexsyn, Averica Discovery Services, Blue Sky BioServices, Peakdale Molecular and 12 more.
Compare Medigen Biosciences to Competitors
Genedata aims to provide computational solutions for drug discovery and systems biology research with a combination of software products and professional services that have been developed in partnership with major pharma and biotech companies.
Medicilon aims to provide integrated drug discovery services to pharmaceutical and biotech companies including chemical synthesis and pharmaceutical services.
IIT Research Institute (IITRI) is a contract research organization (CRO) that aims to provide non-clinical toxicology and other drug development services to government and industry. IITRI offers particular expertise in oncologics drug development, inhalation toxicology and technology, carcinogenesis and cancer prevention, and biodefense. IITRI's Drug Discovery Division is a research-based group whose focus is the design and synthesis of new small molecule therapeutics for cancer and infectious disease.
VivoPath is a preclinical screening company, offering the company's clients discovery and development services for in vivo testing. VivoPath aims to provide integrated in vivo studies led by established experts in drug development. Efficacy is established for animal models in the areas of metabolic disease, inflammation, neurodegenerative disease, and infectious diseases. Formulation screening is carried out to select the most appropriate delivery system for administration. Pharmacokinetic evaluation is carried out to assess exposure and bioavailability. Tolerability is assessed with evaluations of clinical signs, clinical chemistry and hematology. The resulting program aims to deliver the client an in vivo therapeutic index (TI) report on which to assess candidates for subsequent development. VivoPath can also help clients at any individual step in this preclinical screening process. VivoPath's commitment is to provide scientific expertise in in vivo drug discovery in order to increase productivity from research into drug development.
MerLion Pharmaceuticals focuses on the discovery and development of drug candidates from natural sources. MerLion collaborates with leading pharmaceutical companies, biotechs and research institutes to identify and develop drug leads in a wide range of therapeutic areas.
Combichem offers drug discovery and development services